Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 7:12 PM
Study NCT ID:
NCT03573960
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-15
First Post:
2018-06-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Evaluate the Safety and Efficacy of Lenvatinib in Participants With Refractory Differentiated Thyroid Cancer
Sponsor:
Eisai Pharmaceuticals India Pvt. Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-04-30
Completion Date Type:
ESTIMATED
First Submit Date:
2018-06-19
First Submit QC Date:
None
Study First Post Date:
2018-06-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-11
Last Update Post Date:
2025-04-15
Last Update Post Date Type:
ACTUAL